Baxter Healthcare Philippines, Inc., a subsidiary of Baxter International Inc., is a leading player in the healthcare industry, headquartered in the Philippines. Established in 1982, the company has made significant strides in providing essential medical products and services across the region, particularly in areas such as intravenous therapy, renal care, and surgical products. Baxter is renowned for its innovative solutions, including advanced infusion systems and renal replacement therapies, which enhance patient care and safety. With a strong commitment to quality and sustainability, Baxter Healthcare Philippines has positioned itself as a trusted partner in the healthcare sector, contributing to improved health outcomes nationwide. The company continues to achieve notable milestones, reinforcing its reputation as a pioneer in medical technology and patient-centric solutions.
How does Baxter Healthcare Philippines, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Baxter Healthcare Philippines, Inc.'s score of 40 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Baxter Healthcare Philippines, Inc. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Baxter International Inc., which may influence its climate commitments and performance metrics. As part of its corporate family, Baxter Healthcare Philippines inherits climate-related initiatives and targets from Baxter International Inc. This includes participation in the Carbon Disclosure Project (CDP), where emissions data and performance metrics are reported at a higher level. However, specific reduction targets or achievements for Baxter Healthcare Philippines are not detailed in the available information. The company has not publicly committed to any specific science-based targets (SBTi) or documented reduction initiatives at this time. Without concrete emissions data or defined climate pledges, it is challenging to assess the company's current impact or future commitments regarding carbon emissions. In summary, while Baxter Healthcare Philippines, Inc. is part of a larger corporate structure that engages in climate initiatives, specific emissions data and reduction targets for the subsidiary remain unspecified.
Access structured emissions data, company-specific emission factors, and source documents
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 781,365,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Baxter Healthcare Philippines, Inc.'s Scope 3 emissions, which decreased by 10% last year and decreased by approximately 7% since 2009, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 45% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Baxter Healthcare Philippines, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.